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Moringa oleifera (MO) is reported to have various medicinal properties. The aim of 
this study is to evaluate the hepatoprotective effect of MO leaf extract against 
acetaminophen (APAP) induced liver damage in rats. A dose of 3g/kg APAP was 
selected to induce liver damage. Seventy male Sprague-Dawley rats (n=70) were 
divided into seven groups. Five groups of animals were given various oral 
pretreatments of 200mg/kg MO, 800mg/kg MO and 200mg/kg Silymarin (Sil) in 
distilled water at 3ml/day for fourteen days. Meanwhile, two groups served as 
hepatotoxicity (3g/kgAPAP) and vehicle (40% sucrose) control groups were given 
distilled water in the similar manner. On day 15, the animals were challenged with 
3g/kg APAP in 40% sucrose except for rats in the vehicle (40% sucrose) and MO 
control groups which received 40% sucrose solution. After 24 and 48 hours blood 
was withdrawn and livers were harvested. Plasma was prepared and liver function 
was carried out to determine levels of alanine aminotransferase (ALT), aspartate 
aminotransferase (AST) and alkaline phosphatase (ALP). Liver samples were taken 
for histopathalogical examination, measurement of hepatic reduced glutathione 
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(GSH) content, glutathione-S-transferase (GST), glutathione peroxidase (GPx) and 
glutathione reductase (GR) activities as well as determining malondialdehyde 
(MDA) levels. Statistical analysis was performed using analysis of variance 
(ANOVA) and Kruskall Wallis analysis of variance coupled with the Mann–Whitney 
U-test. APAP treatment caused significant elevation (p<0.05) of ALT, AST after 24 
and 48 hours. Histopathological observations substantiated these findings showing 
significant (p<0.05) liver damage. APAP treatment caused marked reduction 
(p<0.05) in hepitic GSH content, GST and GPx. activities coupled with significant 
increase (p< 0.05) in lipid peroxidation index. The changes observed were 
time dependent with more changes were noted after 48 hours. Significant (p<0.05) 
elevation of ALP and significant (p<0.05) decline of GR activity was only noted 
after 48 hours compared to other groups. 200mg/kg and 800mg/kg MO extract 
equally showed a significant (p<0.05) amelioration of ALT, AST and ALP levels and 
a significant reduction (p<0.05) of pathological alteration in a manner similar to Sil. 
MO extracts showed no signs of toxicity up to a dose level of 800 mg/kg. MO alone 
significantly increased (p<0.05) GSH content and restored GSH level (p<0.05) in the 
groups given MO and challenged with APAP. MO alone showed insignificant 
increase of GST, Gap and GR activities. The significant increase (p<0.05) of these 
antioxidant enzymes observed in groups received MO extracts and challenged with 
APAP. Lipid peroxidation was significantly (p<0.05) inhibited by the extracts in 
dose independent manner. A significant (p<0.05) increase of GST activities by 
200mg/kg and 800mg/kg MO extracts to the level higher than vehicle group were 
observed as early as 24 hours  in comparison with rats given pretreatment of 
Silymarin. On the other hand, 200 mg/kg MO significantly (p<0.05) showed similar 
increase in GPx activity to the level higher than vehicle group in comparison with  
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groups that given 200mg/kg Sil and 800mg/kg MO  pretreatment. Prevention of 
enzyme leakage, preservation of hepatocytes structural integrity, prevention of GSH 
depletion, restoration of antioxidant enzymes activity that is essential in accelerating 
detoxification and excretion of APAP toxic metabolites, as well inhibition of lipid 
peroxidative processes reveals that the extracts of MO leaves possesses potential 
hepatoprotective activity against APAP induced damage in rats. 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
memenuhi keperluan untuk ijazah Master Sains 
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Moringa oleifera (MO) dilaporkan mengandungi pelbagai nilai perubatan. Tujuan 
kajian ini dijalankan adalah untuk melihat kesan hepatoprotektif ekstrak daun MO 
terhadap kerosakan hepar tikus yang dicetuskan oleh acetaminophen (APAP). Dalam 
kajian ini, dos sebanyak 3g/kg APAP telah dipilih untuk mecetuskan kerosakan 
hepar. Tikus jantan Sprague dawley (n=70) telah dibahagikan kepada 7 kumpulan. 
Lima kumpulan menerima pelbagai jenis rawatan  seperti 200mg/kg MO, 800mg/kg 
MO, 200mg/kg silymarin (Sil) dalam air suling secara oral pada 3ml setiap hari 
untuk empat belas hari. Tikus dalam kumpulan kawalan hepatotoxicity (3g/kg 
APAP) dan sukrosa 40% hanya diberi air suling dengan cara yang sama. Pada hari 
ke-15 tikus diberi 3g/kg APAP dalam 40% sukrosa kecuali kumpulan tikus kawalan 
dalam sukrosa dan MO yang menerima 40% sukrosa. Selepas 24 dan 48 jam, sampel 
darah diambil dan hepar dikeluarkan. Plasma disediakan untuk ujian fungsi hati yang 
merangkumi alanine aminotranferase (ALT), aspartate aminotransferase (AST) dan 
alkaline phosphatase (ALP). Sampel hepar diambil untuk kajian histopatologi, 
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penentuan aras glutathione (GSH) hepar, analisis aktiviti glutathione-S–transferase 
(GST), glutathione peroxidase (GPx), dan glutathione reductase (GR) serta aras 
malondialdehyde (MDA). Data dianalisis menggunakan analisi varians (ANOVA) 
dan Kruskall Wallis analisi varians dengan Mann–Whitney U-test. Hasil menunjukan 
bahawa rawatan APAP menyebabkan peningkatan aras ALT dan AST yang 
signifikan (p<0.05) selepas 24 dan 48 jam. Kajian histopatologi menyokong 
penemuan tersebut yang menunjukkan kerosakan hati (p<0.05). APAP menyebabkan 
penurunan signifikan (p<0.05) aras GSH, aktiviti GST dan GPx. serta menunjukkan 
peningkatan (p<0.05) dalam peroksidasi lemak. Perubahan yang diperhatikan adalah 
bergantung pada masa dengan lebih ketara (p<0.05) selepas 48 jam. Peningkatan 
ALP dan pengurangan aktiviti GR hanya signifikan (p<0.05) selepas 48 jam 
berbanding kumpulan lain. Kedua-dua dos MO ekstrak menunjukkan penurunan 
signifikan (p<0.05) yang setara dalam pemulihan aras AST, ALT dan ALP serta 
pengurangan perubahan patologi sepertimana diperhatikan pada Sil. Rawatan dengan 
ekstrak MO tidak menunjukkan kesan toksik setakat dos 800mg/kg. Ekstrak MO 
sahaja telah meningkatkan aras glutathione hepar (p<0.05) dan MO yang diberi 
bersama rawatan APAP menunjukkan pemeliharaan signifikan (p<0.05) aras GSH. 
Penigkatan aktiviti GST, GPx dan GR oleh MO sahaja adalah tidak signifikan. MO 
bersama cabaran APAP telah merangsangkan aktiviti-aktiviti enzim antioksidan 
tersebut. Peroksidasi lemak telah direncatkan secara signifikan (p<0.05)  oleh MO 
tanpa dipengaruhi oleh dos. Dos 200mg/kg MO menujukkan keupayaan dalam 
rangsangan aktiviti GST yang signifikan (p<0.05) berbanding silymarin apabila 
menunjukan aktiviti yang tinggi melebihi kumpulan sukrosa seawal 24 jam. 
Manakala 200mg/kg MO juga merangsangkan aktitiviti GPx dengan lebih ketara 
(p<0.05) berbanding dengan kumpulan 800mg/kg MO dan Sil, dengan menunjukan 
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aktiviti melebihi kumpulan sukrosa seawal 24 jam. Pemulihan aras enzim-enzim 
yang menunjukan fungsi normal hati, pemeliharaan struktur cell hepar, pemeliharaan 
aras glutathione hati serta pemulihan aktiviti-aktiviti enzim antioksida yang 
memainkan peranan dalam penyahtoksikan metabolit APAP dan perencatan 
proksidasi lemak menunjukan bahawa MO menjanjikan aktiviti hepatoprotektif 
terhadap kerosakan hepar cetusan APAP. 
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4.1.1 
 
 
 
Photomicrograph of rat liver section of rats given normal 
saline after 24 hours. The section demonstrates normal 
lobular architecture and normal hepatic cells with a well 
preserved cytoplasm and well-defined nucleus around 
perivenular area (PV). Magnification: 200x 
 
61 
4.1.2 Photomicrograph of rat liver with normal saline after 24 
hours. The section demonstrated normal lobular architecture 
and normal hepatic cells with a well preserved cytoplasm 
and well-defined nucleus around portal tract (PT) area. 
Magnification: 200x 
 
61 
4.1.3 Photomicrograph of rat liver with section of rats given 
normal saline after 48 hours. The section demonstrated 
normal architecture of hepatocytes, around perivenular area 
(PV) as well as portal tract (PT) area Magnification: 100x 
 
62 
4.1.4  Photomicrograph of rat liver with normal saline after 72 
hours. The section demonstrated normal architecture of 
hepatocytes, around perivenular area (PV). Magnification: 
200x  
 
62 
4.1.5 Photomicrograph of rat liver with normal saline after 72 
hours. The section exhibited normal architecture of 
hepatocytes, around portal tract area (PT). Magnification: 
200x  
 
63 
4.1.6 Photomicrograph of rat liver with 100mg/kg APAP i.p after 
24 hours. The section demonstrated normal architecture of 
hepatocytes, around perivenular area (PV) with focal 
infiltration of lymphocytes (Æ) Magnification: 200x 
 
65 
4.1.7 Photomicrograph of rat liver with 100mg/kg APAP i.p after 
24 hours. The section demonstrated normal architecture of 
hepatocytes, around portal tract area (PT). Magnification: 
200x  
 
65 
4.1.8 Photomicrograph of rat liver with 100mg/kg APAP i.p after 
48 hours. The section demonstrated normal architecture of 
hepatocytes, with slight hydropic appearance (Æ) around 
perivenular area (PV). Magnification: 200x 
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xix
4.1.9 Photomicrograph of rat liver with 100mg/kg APAP i.p after 
48 hours. The section demonstrated normal architecture of 
hepatocytes, around portal tract area (PT). Magnification: 
200x  
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4.1.10 Photomicrograph of rat liver with 100mg/kg APAP i.p after 
72 hours. The section demonstrated scattered fatty changes 
(Æ) around perivenular area   (PV). Magnification: 200x  
 
67 
4.1.11 Photomicrograph of rat liver with 100mg/kg APAP i.p after 
72 hours. The section demonstrated normal architecture of 
hepatocytes, around portal tract area (PT) with congestion of 
RBC in the sinusoids Magnification: 200x 
 
67 
4.1.12 Photomicrograph of rat liver with 200mg/kg APAP i.p after 
24 hours. The section demonstrated moderate fatty changes 
(Æ) around perivenular area   (PV). Magnification: 200x  
 
69 
4.1.13 Photomicrograph of rat liver with 200mg/kg APAP i.p after 
24 hours. The section demonstrated normal architecture of 
hepatocytes, around portal tract area (PT). Magnification: 
200x  
 
69 
4.1.14 Photomicrograph of rat liver with 200mg/kg APAP i.p after 
48 hours. The section demonstrated normal architecture of 
hepatocytes, around perivenular area (PV) with focal 
scattered infiltration of lymphocytes (Æ) Magnification: 
400x 
 
70 
4.1.15 Photomicrograph of rat liver with 200mg/kg APAP i.p after 
48 hours. The section demonstrated slightly hydropic (HD) 
hepatocytes around perivenular area (PV) with scattered 
focal infiltration of lymphocytes (L) and microvesiculation 
(M). Magnification: 200x 
 
70 
4.1.16 Photomicrograph of rat liver with 200mg/kg APAP i.p after 
48 hours. The section demonstrated normal architecture of 
hepatocytes, around portal tract area (PT). Magnification: 
200x 
 
71 
4.1.17 Photomicrograph of rat liver with 200mg/kg APAP i.p and 
after 72 hours. The section demonstrated hepatocytes with 
focal scattered microvesiculation with congestion of RBC in 
the sinusoids (Æ). Magnification: 200x 
 
71 
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4.1.18 Photomicrograph of rat liver with 200mg/kg APAP i.p after 
72 hours. The section demonstrated slightly hydropic (Æ) 
hepatocytes around perivenular area (PV).Magnification: 
200x  
 
72 
4.1.9 Photomicrograph of rat liver with 200mg/kg APAP i.p after 
72 hours. The section demonstrated normal architecture of 
hepatocytes, around portal tract area (PT).  Magnification: 
200x 
 
72 
4.2.1 Plasma alanine aminotransferase (ALT) level, following 
different doses of APAP administration after 24, 48 and 72 
hours. Results are expressed as means ± SEM. a Groups are 
compared with 40% sucrose control c Groups are compared 
with 2g/kg APAP at 24 hours. dGroups are compared with 
2g/kg APAP at 72 hours. All values are statistically different 
(p<0.05). 
 
74 
4.2.2 Plasma aspartate aminotransferase (AST) level, following 
different doses of APAP administration after 24, 48 and 72 
hours. Results are expressed as means ± SEM. a Groups are 
compared with 40% sucrose control. bGroups are compared 
2g/kg control at 24 hours. c Groups are compared 2g/kg 
control at 72 hours. c Groups are compared 1g/kg control at 
24 hours All values are statistically different (p<0.05). 
 
76 
4.2.3 
 
 
 
 
 
4.2.4 
Photomicrograph shows liver section of rats given 40% 
sucrose and sacrificed after 24 hours. The section showed 
normal cellular architecture with distinct hepatic cells, 
around perivenular area (PV) as well as around portal tract 
(PT).Magnification:100x 
 
Photomicrograph shows liver section of rats given 40% 
sucrose and sacrificed after 48 hours. The section 
demonstrated normal architecture of hepatocytes, around 
perivenular (PV) and portal tract (PT) area. Magnification: 
100x 
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4.2.5 Photomicrograph shows liver section of rats given 40% 
sucrose and sacrificed after 72 hours. The section 
demonstrated normal architecture of hepatocytes, around 
perivenular (PV) area as well as portal tract (PT) area 
.Magnification:100x 
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4.2.6 Photomicrograph shows liver section of rats challenged with 
1g/kg APAP and sacrificed after 24 hours. The section 
demonstrated diffuse scattered microvesiculation (Æ).  
Magnification: 200x 
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4.2.7 Photomicrograph shows liver section of rats challenged with 
1g/kg APAP and sacrificed after 24 hours. The section 
demonstrated presence of cluster of lymphocytes (Æ) around 
perivenular (PV) area with normal appearance of hepatocyes 
around portal tract (PT) area. Magnification: 100x 
 
82 
4.2.8 Photomicrograph shows liver section of rats challenged with 
1g/kg APAP and sacrificed after 48 hours. The section 
demonstrated diffuse microvesiculation (Æ) around 
perivenular area (PV).  Magnification: 200x 
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4.2.9 Photomicrograph shows liver section of rats challenged with 
1g/kg APAP and sacrificed after 48 hours. The section 
demonstrated clusters of lymphocyte infiltration (Æ).  
Magnification: 200x 
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4.2.10 Photomicrograph shows liver section from rat treated with 
1g/kg APAP sacrificed 72 hours post-treatment. The section 
reveals presence of massive infiltration of lymphocytes and 
neutrophills (Æ) around perivenular area (PV). 
Magnification: 100x 
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4.2.11 Photomicrograph shows liver section from rat treated with 
1g/kg APAP sacrificed 72 hours post-treatment. The section 
reveals presence of massive infiltration of lymphocytes and 
neutrophills (Æ) around perivenular area (PV). 
Magnification: 200x 
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4.2.12 Photomicrograph shows liver section of rats challenged with 
2g/kg APAP and sacrificed after 24 hours. The section 
demonstrated infiltration of lymphocytes (Æ) around 
perivenular (PV) area Magnification: 200x           
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4.2.13 Photomicrograph shows liver section of rats challenged with 
2g/kg APAP and sacrificed after 24 hours. The section 
indicates cluster of lymphocytes (Æ) around some 
perivenular (PV) area Magnification:200x 
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4.2.14 Photomicrograph shows liver section of rats challenged with 
2g/kg APAP and sacrificed after 24 hours. The section 
demonstrated well preserved architecture of hepatocytes, 
around portal tract area (PT).  Magnification: 200x 
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4.2.15 Photomicrograph shows liver section from rat treated with 
2g/kg APAP sacrificed 48 hours post-treatment. The section 
reveals diffuse infiltration of lymphocytes and neutrophills 
(N) presence of diffuse microvesiculation (M), focal 
individual necrotic debris (NC) around perivenular area 
(PV). Magnification: 200x 
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4.2.16 Photomicrograph shows liver section from rat treated with 
2g/kg APAP sacrificed 48 hours post-treatment. The section 
reveals disintegration of hepatocytes around perivenular area 
(PV) with diffuse infiltration of lymphocytes (L), 
neutrophills (Ne), necrotic debris (ND) and prominent 
microvesiculation (M). Hepatocytes around portal tract (PT) 
was well preserved. Magnification: 100x 
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4.2.17 Photomicrograph shows liver section of rats challenged with 
2g/kg APAP and sacrificed after 72 hours. The section 
indicates cluster of lymphocytes (Æ) around some 
perivenular (PV) area Magnification:100x 
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4.2.18 Photomicrograph shows liver section of rats challenged with 
2g/kg APAP and sacrificed after 72 hours. The section 
indicates presence of microvesiculation (Æ) around some 
perivenular (PV) area Magnification:200x 
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4.2.19 
 
 
 
 
 
Photomicrograph shows liver section of rats challenged with 
2g/kg APAP and sacrificed after 72 hours. The section 
demonstrated well preserved architecture of hepatocytes, 
around portal tract area (PT).  Magnification: 200x  
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4.3.1 The effect of Moringa oleifera pretreatment on plasma 
Alanine Aminotransferase (ALT) level, following APAP 
administration after 24 and 48 hours. Results are expressed 
as means ± SEM. a Groups are compared with 40% sucrose 
control. b Groups compared with group 3g/kg APAP at 24 
hours. c Groups compared with group 3g/kg APAP at 
48hours All values are statistically different (p<0.05). 
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4.3.2 The effect of Moringa oleifera pretreatment on plasma 
Aspartate Aminotransferase (AST) level, following APAP 
administration after 24 and 48 hours. Results are expressed 
as means ± SEM. a Groups are compared with 40% sucrose 
control. b Groups compared with group 3g/kg APAP at 24 
hours. c Groups compared with group 3g/kg APAP at 
48hours.  All values are statistically different (p<0.05). 
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